DUBLIN--(BUSINESS WIRE)--The "OTC/DTC Infectious Disease Diagnostics Strategies and Trends for Over the Counter and Direct to Consumer. Forecasts by Application by Channel by Country. With Market Analysis, Executive Guides, and Market Opportunity Analysis 2023 to 2027" report has been added to ResearchAndMarkets.com's offering. 'OTC/DTC Infectious Disease Diagnostics Strategies and Trends for Over the Counter and Direct to Consumer. Forecasts by Application by Channel by Country. With Market Analysis, Executive Guides, and Market Opportunity Analysis 2023 to 2027' The sleeping giant of Over the Counter and Direct to Consumer diagnostics is set to create a broad new diagnostic industry. New technologies create rapid test solutions for the home market. Self-Sampling technology key.
Genetic DTC testing led the way. Now Infectious disease testing is moving directly to the consumer. New sampling technology, rapid and multiplex tests have changed the picture on how and where testing is done. And the pandemic has proven the need for self testing. This report explores the DTC outlook for different syndromes. Find out where the action is and the learn about the players. Exciting technical developments especially in the seesaw between PCR and immunoassay, hold the promise of a dynamic, growing and evolving world market that holds the promise of diagnostics taking the lead in infectious disease eradication. Even CRISPR diagnostics are now coming into play. The report has hundreds of pages of information including a complete list of Current United States Medicare Fee Payment Schedules to help sharpen your pricing.
2 Introduction and Market Definition
4.1 Industry Participants
4.2 The Clinical Laboratory Market Segments
5.1 Factors Driving Growth
5.2 Factors Limiting Growth
5.3 Diagnostic Technology Development
6.1 Recent Developments - Importance and How to Use This Section
6.2 FDA Authorizes First OTC Home Test for both Influenza and COVID- 6.3 Pharmacies Poised to Capture At-Home Diagnostics Category
6.4 How Labcorp, Abbott, BD, Siemens plan to expand home testing market 6.5 Morgan Health Invests in LetsGetChecked
6.6 New US$ 1 price for HIV self-tests
6.7 Startup Detect to Roll Out Next-Gen Molecular Instrument
6.8 Diagnostics for the Real World Third-Generation POC Platform
6.9 Labcorp Partnering With Getlabs for Home Collection 6.11 Cue Health Targets DTC Market in 2
6.14 MFB Fertility Closes Series A Financing Round
6.15 Continued Demand for SARS-CoV-2 Rapid Tests
6.16 Rapid Covid-19 Test Results Risk Going Uncounted 6.17 FDA Grants EUAs for Direct-to-Consumer Coronavirus Kit
6.18 Researchers Develop 15-Minute PCR System
6.19 Stanford Developing Low-Cost, At-Home, COVID-19 Saliva Test 6.20 Lucira Health Files for $115M IPO 6.24 FemtoDx Launches Rapid At-Home Test Development for COVID- 6.25 FDA approves first at-home coronavirus test
6.27 Biohacking trend supports self testing.
6.31 Nigerian Govt Approves Alere HIV Self-Test Kit
6.32 Boots launches UTI test and treat service across 37 branches 6.34 Healthy.io raises $18 million for at-home urinalysis tests 6.35 LetsGetChecked collects $30M more for at-home health testing
6.36 TestCard, a $4 Urine Test Read by Smartphone
6.37 Digital Health Startup EverlyWell Raises $50M
6.38 Thriva adds test-at-home kits for female hormone and cortisol stress
6.39 Tasso scores $6.1M for patch-based home blood testing 6.41 Abbott HbA1c point-of-care test reliably diagnoses diabetes 7 Profiles of Key Diagnostic Testing Companies
9 Global Market by Syndrome
10 Global Market by Channel
For more information about this report visit https://www.researchandmarkets.com/r/rm4tt0
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.